| 2025-10-30 |
详情>>
股本变动：
变动后总股本5909.66万股
|
| 2025-10-30 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.35美元,归母净利润-7928.7万美元,同比去年增长-466.82%
|
| 2025-10-29 |
财报披露：
美东时间 2025-10-29 盘后发布财报
|
| 2025-08-07 |
详情>>
内部人交易：
Polymeropoulos Mihael Hristos股份增加10000.00股
|
| 2025-07-31 |
详情>>
业绩披露：
2025年中报每股收益-0.96美元,归母净利润-5670.1万美元,同比去年增长-554.44%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益-0.5美元,归母净利润-2949.4万美元,同比去年增长-611.38%
|
| 2025-04-25 |
股东大会：
将于2025-06-05召开股东大会
会议内容 ▼▲
- 1.To elect Stephen Ray Mitchell, M.D. and Tage Honoré, Ph.D., D.Sc. as Class I directors until the 2028 annual meeting of stockholders;
2.To ratify the selection, by the Audit Committee of the Company’s Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2025;
3.To approve, on an advisory basis, the Company’s named executive officer compensation;
4.To approve an amendment to the Company’s Amended and Restated 2016 Equity Incentive Plan, as amended (the “2016 Plan”), to (i) increase the aggregate number of shares authorized for issuance thereunder and (ii) eliminate its term;
5.To conduct any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2025-02-14 |
详情>>
业绩披露：
2024年年报每股收益-0.33美元,归母净利润-1890万美元,同比去年增长-853.29%
|
| 2025-02-14 |
详情>>
业绩披露：
2022年年报每股收益0.11美元,归母净利润627.50万美元,同比去年增长-81.07%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.24美元,归母净利润-1398.8万美元,同比去年增长-384.95%
|
| 2024-08-01 |
详情>>
业绩披露：
2024年中报每股收益-0.15美元,归母净利润-866.4万美元,同比去年增长-281.56%
|
| 2024-08-01 |
详情>>
业绩披露：
2023年中报每股收益0.08美元,归母净利润477.20万美元,同比去年增长223.76%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益-0.07美元,归母净利润-414.6万美元,同比去年增长-227.49%
|
| 2024-04-29 |
股东大会：
将于2024-05-17召开股东大会
会议内容 ▼▲
- 1.To elect Mihael H. Polymeropoulos, M.D. and Phaedra S. Chrousos as Class III directors until the 2027 annual meeting of stockholders;
2.To ratify the selection, by the Audit Committee of the Company’s Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2024;
3.To approve, on an advisory basis, the Company’s named executive officer compensation;
4.To approve an amendment to the Company’s Amended and Restated 2016 Equity Incentive Plan, as amended (the “2016 Plan”), to increase the aggregate number of shares authorized for issuance under the 2016 Plan;
5.To conduct any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2024-02-08 |
详情>>
业绩披露：
2023年年报每股收益0.04美元,归母净利润250.90万美元,同比去年增长-60.02%
|
| 2023-12-07 |
复牌提示：
2023-12-07 06:55:21 停牌，复牌日期 2023-12-07 07:30:00
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.09美元,归母净利润490.90万美元,同比去年增长937.71%
|
| 2023-04-24 |
股东大会：
将于2023-06-08召开股东大会
会议内容 ▼▲
- 1.To elect Richard W. Dugan and Anne Sempowski Ward as Class II directors until the 2026 annual meeting of stockholders;
2.To ratify the selection by the Audit Committee of our Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2023;
3.To approve, on an advisory basis, the named executive officer compensation;
4.To vote on the frequency of future advisory votes on named executive officer compensation;
5.To approve an amendment to the Company's Amended and Restated 2016 Equity Incentive Plan, as amended ("2016 Plan"), to increase the aggregate number of shares authorized for issuance under the 2016 Plan;
6.To conduct any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2022-04-25 |
股东大会：
将于2022-06-16召开股东大会
会议内容 ▼▲
- 1.To elect Stephen Ray Mitchell to serve as the Class I director until the 2025 annual meeting of stockholders;
2.To ratify the selection by the Audit Committee of our Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2022;
3.To approve on an advisory basis the named executive officer compensation;
4.To approve an amendment to the Company's Amended and Restated 2016 Equity Incentive Plan, as amended ("2016 Plan"), to increase the aggregate number of shares authorized for issuance under the 2016 Plan;
5.To conduct any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-22 |
股东大会：
将于2021-06-10召开股东大会
会议内容 ▼▲
- 1.To elect Mihael H. Polymeropoulos, M.D. and Phaedra Chrousos to serve as Class III directors until the 2024 annual meeting of stockholders;
2.To ratify the selection by the Audit Committee of our Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2021;
3.To approve on an advisory basis the named executive officer compensation;
4.To approve an amendment to the Company's Amended and Restated 2016 Equity Incentive Plan ("2016 Plan") to increase the aggregate number of shares authorized for issuance under the 2016 Plan;
5.To conduct any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2020-04-22 |
股东大会：
将于2020-06-11召开股东大会
会议内容 ▼▲
- 1.To elect Richard W. Dugan and Anne Sempowski Ward to serve as Class II directors until the 2023 annual meeting of stockholders;
2.To ratify the selection by the Audit Committee of our Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2020;
3.To approve on an advisory basis the named executive officer compensation;
4.To approve an amendment and restatement of the Company’s amended and restated 2016 Equity Incentive Plan (“2016 Plan”) to, among other things, increase the aggregate number of shares authorized for issuance under the 2016 Plan;
5.To conduct any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2019-04-25 |
股东大会：
将于2019-06-13召开股东大会
会议内容 ▼▲
- 1.To elect Michael F. Cola and H. Thomas Watkins to serve as Class I directors until the 2022 annual meeting of stockholders;
2.To ratify the selection by the Audit Committee of our Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2019;
3.To approve on an advisory basis the named executive officer compensation;
4.To conduct any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2018-04-27 |
股东大会：
将于2018-06-13召开股东大会
会议内容 ▼▲
- 1.To elect Mihael H. Polymeropoulos, M.D. to serve as a Class III director until the 2021 annual meeting of stockholders;
2.To ratify the selection by the Audit Committee of our Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2018;
3.To approve on an advisory basis the named executive officer compensation;
4.To approve an amendment and restatement of the Company’s amended and restated 2016 Equity Incentive Plan (“2016 Plan”) to, among other things, increase the aggregate number of shares authorized for issuance under the 2016 Plan;
5.To conduct any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2017-04-27 |
股东大会：
将于2017-06-15召开股东大会
会议内容 ▼▲
- 1.To elect Richard W. Dugan and Vincent J. Milano to serve as Class II directors until the 2020 annual meeting of stockholders;
2.To ratify the selection by the Audit Committee of our Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2017;
3.To approve on an advisory basis the named executive officer compensation;
4.To vote on the frequency of advisory votes on executive compensation;
5.To approve the amendment and restatement of the Company’s 2016 Equity Incentive Plan to, among other things, increase the aggregate number of shares authorized for issuance under the 2016 Equity Incentive Plan;
6.To conduct any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|
| 2016-04-28 |
股东大会：
将于2016-06-16召开股东大会
会议内容 ▼▲
- 1.To elect Michael F. Cola and H. Thomas Watkins to serve as Class I directors until the 2019 annual meeting of stockholders;
2.To ratify the selection by the Audit Committee of our Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2016;
3.To approve on an advisory basis the named executive officer compensation;
4.To approve the Vanda Pharmaceuticals Inc. 2016 Equity Incentive Plan;
5.To conduct any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
|